106 related articles for article (PubMed ID: 1913645)
21. Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype.
Caporaso N; Hayes RB; Dosemeci M; Hoover R; Ayesh R; Hetzel M; Idle J
Cancer Res; 1989 Jul; 49(13):3675-9. PubMed ID: 2731181
[TBL] [Abstract][Full Text] [Related]
22. Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes.
Bernert JT; Jain RB; Pirkle JL; Wang L; Miller BB; Sampson EJ
Nicotine Tob Res; 2005 Oct; 7(5):729-38. PubMed ID: 16191744
[TBL] [Abstract][Full Text] [Related]
23. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung.
Wiencke JK; Kelsey KT; Varkonyi A; Semey K; Wain JC; Mark E; Christiani DC
Cancer Res; 1995 Nov; 55(21):4910-4. PubMed ID: 7585529
[TBL] [Abstract][Full Text] [Related]
24. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
Randerath K; Liehr JG; Gladek A; Randerath E
IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
[TBL] [Abstract][Full Text] [Related]
25. Molecular epidemiology of bladder cancer.
Vineis P; Martone T
Ann Ist Super Sanita; 1996; 32(1):21-7. PubMed ID: 8967722
[TBL] [Abstract][Full Text] [Related]
26. Comparison of DNA adducts and sister chromatid exchange in lung cancer cases and controls.
Perera F; Mayer J; Jaretzki A; Hearne S; Brenner D; Young TL; Fischman HK; Grimes M; Grantham S; Tang MX
Cancer Res; 1989 Aug; 49(16):4446-51. PubMed ID: 2743334
[TBL] [Abstract][Full Text] [Related]
27. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.
Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
IARC Sci Publ; 1988; (89):133-6. PubMed ID: 3198197
[TBL] [Abstract][Full Text] [Related]
28. In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin.
Green LC; Skipper PL; Turesky RJ; Bryant MS; Tannenbaum SR
Cancer Res; 1984 Oct; 44(10):4254-9. PubMed ID: 6467185
[TBL] [Abstract][Full Text] [Related]
29. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
[TBL] [Abstract][Full Text] [Related]
30. Analysis of 4-ABP-DNA adducts and p53 alterations in urinary bladder carcinoma.
Romano G; Garagnani L; Boninsegna A; Ferrari P; Flamini G; De Gaetani C; Sgambato A; Giovanni F; Curigliano G; Ferretti G; Cittadini A; Trentini G
Anticancer Res; 1999; 19(5C):4571-6. PubMed ID: 10650812
[TBL] [Abstract][Full Text] [Related]
31. DNA adducts and lung cancer risk: a prospective study.
Peluso M; Munnia A; Hoek G; Krzyzanowski M; Veglia F; Airoldi L; Autrup H; Dunning A; Garte S; Hainaut P; Malaveille C; Gormally E; Matullo G; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Trichopoulos D; Kaladidi A; Palli D; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Kumle M; Gonzalez CA; Martinez C; Dorronsoro M; Barricarte A; Navarro C; Quiros JR; Berglund G; Janzon L; Jarvholm B; Day NE; Key TJ; Saracci R; Kaaks R; Riboli E; Vineis P
Cancer Res; 2005 Sep; 65(17):8042-8. PubMed ID: 16140979
[TBL] [Abstract][Full Text] [Related]
32. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers.
Hammond SK; Coghlin J; Gann PH; Paul M; Taghizadeh K; Skipper PL; Tannenbaum SR
J Natl Cancer Inst; 1993 Mar; 85(6):474-8. PubMed ID: 8445675
[TBL] [Abstract][Full Text] [Related]
33. Phenobarbital, drug metabolism, and human cancer.
Olsen JH; Wallin H; Boice JD; Rask K; Schulgen G; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):449-52. PubMed ID: 8220089
[TBL] [Abstract][Full Text] [Related]
34. The use of biomarkers in epidemiology: the example of bladder cancer.
Vineis P
Toxicol Lett; 1992 Dec; 64-65 Spec No():463-7. PubMed ID: 1471198
[TBL] [Abstract][Full Text] [Related]
35. Potential role of cytochrome P450-1B1 in the metabolic activation of 4-aminobiphenyl in humans.
Ketelslegers HB; Godschalk RW; Eskens BJ; Dallinga JW; Gottschalk RW; van Schooten FJ; van Delft JH; Kleinjans JC
Mol Carcinog; 2009 Aug; 48(8):685-91. PubMed ID: 19274671
[TBL] [Abstract][Full Text] [Related]
36. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.
Bryant MS; Skipper PL; Tannenbaum SR; Maclure M
Cancer Res; 1987 Jan; 47(2):602-8. PubMed ID: 3791245
[TBL] [Abstract][Full Text] [Related]
37. Decline of the hemoglobin adduct of 4-aminobiphenyl during withdrawal from smoking.
Maclure M; Bryant MS; Skipper PL; Tannenbaum SR
Cancer Res; 1990 Jan; 50(1):181-4. PubMed ID: 2293553
[TBL] [Abstract][Full Text] [Related]
38. DNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis.
Veglia F; Loft S; Matullo G; Peluso M; Munnia A; Perera F; Phillips DH; Tang D; Autrup H; Raaschou-Nielsen O; Tjønneland A; Vineis P;
Carcinogenesis; 2008 May; 29(5):932-6. PubMed ID: 18343884
[TBL] [Abstract][Full Text] [Related]
39. HPLC and GC/MS determination of 4-aminobiphenyl haemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero.
Pinorini-Godly MT; Myers SR
Toxicology; 1996 Mar; 107(3):209-17. PubMed ID: 8604481
[TBL] [Abstract][Full Text] [Related]
40. A molecular epidemiological case-control study of lung cancer.
Tang D; Santella RM; Blackwood AM; Young TL; Mayer J; Jaretzki A; Grantham S; Tsai WY; Perera FP
Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):341-6. PubMed ID: 7655328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
